{"id":"https://openalex.org/W7223648928","doi":"https://doi.org/10.1002/cam4.72423","title":"Efficacy and Safety of Apixaban Thromboprophylaxis According to Baseline Chemotherapy Class in High\u2010Risk Ambulatory Cancer Patients: A Post Hoc Analysis of the AVERT Trial","display_name":"Efficacy and Safety of Apixaban Thromboprophylaxis According to Baseline Chemotherapy Class in High\u2010Risk Ambulatory Cancer Patients: A Post Hoc Analysis of the AVERT Trial","publication_year":2026,"publication_date":"2026-10-25","ids":{"openalex":"https://openalex.org/W7223648928","doi":"https://doi.org/10.1002/cam4.72423","pmid":"https://pubmed.ncbi.nlm.nih.gov/42928572","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13696908"},"language":"en","primary_location":{"id":"doi:10.1002/cam4.72423","doi":"https://doi.org/10.1002/cam4.72423","is_oa":true,"landing_page_url":"https://doi.org/10.1002/cam4.72423","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cam4.72423","source":{"id":"https://openalex.org/S2754843627","display_name":"Cancer Medicine","issn_l":"2045-7634","issn":["2045-7634"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Medicine","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cam4.72423","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5157591003","display_name":"Nadia Linxi Feng","orcid":"https://orcid.org/0009-0002-1966-2146","observed_orcids":["https://orcid.org/0009-0002-1966-2146"]},"institutions":[{"id":"https://openalex.org/I5023651","display_name":"McGill University","ror":"https://ror.org/01pxwe438","country_code":"CA","type":"education","lineage":["https://openalex.org/I5023651"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Nadia Linxi Feng","raw_affiliation_strings":["Faculty of Medicine McGill University  Montreal Quebec Canada"],"raw_orcid":"https://orcid.org/0009-0002-1966-2146","affiliations":[{"raw_affiliation_string":"Faculty of Medicine McGill University  Montreal Quebec Canada","institution_ids":["https://openalex.org/I5023651"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5157480133","display_name":"John Doering","orcid":"https://orcid.org/0009-0006-2849-0461","observed_orcids":["https://orcid.org/0009-0006-2849-0461"]},"institutions":[{"id":"https://openalex.org/I141945490","display_name":"University of British Columbia","ror":"https://ror.org/03rmrcq20","country_code":"CA","type":"education","lineage":["https://openalex.org/I141945490"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"John Doering","raw_affiliation_strings":["Department of Medicine University of British Columbia  Vancouver British Columbia Canada"],"raw_orcid":"https://orcid.org/0009-0006-2849-0461","affiliations":[{"raw_affiliation_string":"Department of Medicine University of British Columbia  Vancouver British Columbia Canada","institution_ids":["https://openalex.org/I141945490"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033748408","display_name":"Tzu\u2010Fei Wang","orcid":"https://orcid.org/0000-0003-2407-9000","observed_orcids":["https://orcid.org/0000-0003-2407-9000"]},"institutions":[{"id":"https://openalex.org/I153718931","display_name":"University of Ottawa","ror":"https://ror.org/03c4mmv16","country_code":"CA","type":"education","lineage":["https://openalex.org/I153718931"]},{"id":"https://openalex.org/I2800722420","display_name":"Ottawa Hospital","ror":"https://ror.org/03c62dg59","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2800722420"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Tzu\u2010Fei Wang","raw_affiliation_strings":["Department of Medicine University of Ottawa at the Ottawa Hospital  Ottawa Ontario Canada"],"raw_orcid":"https://orcid.org/0000-0003-2407-9000","affiliations":[{"raw_affiliation_string":"Department of Medicine University of Ottawa at the Ottawa Hospital  Ottawa Ontario Canada","institution_ids":["https://openalex.org/I153718931","https://openalex.org/I2800722420"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005699907","display_name":"Ranjeeta Mallick","orcid":"https://orcid.org/0000-0002-0227-5687","observed_orcids":["https://orcid.org/0000-0002-0227-5687"]},"institutions":[{"id":"https://openalex.org/I4388482656","display_name":"Ottawa Hospital Research Institute","ror":"https://ror.org/05jtef216","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I153718931","https://openalex.org/I2800722420","https://openalex.org/I4388482656"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Ranjeeta Mallick","raw_affiliation_strings":["Method Center The Ottawa Hospital Research Institute  Ottawa Ontario Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Method Center The Ottawa Hospital Research Institute  Ottawa Ontario Canada","institution_ids":["https://openalex.org/I4388482656"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051047770","display_name":"Gr\u00e9goire Le Gal","orcid":"https://orcid.org/0000-0002-9253-248X","observed_orcids":["https://orcid.org/0000-0002-9253-248X"]},"institutions":[{"id":"https://openalex.org/I153718931","display_name":"University of Ottawa","ror":"https://ror.org/03c4mmv16","country_code":"CA","type":"education","lineage":["https://openalex.org/I153718931"]},{"id":"https://openalex.org/I2800722420","display_name":"Ottawa Hospital","ror":"https://ror.org/03c62dg59","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2800722420"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Gr\u00e9goire Le Gal","raw_affiliation_strings":["Department of Medicine University of Ottawa at the Ottawa Hospital  Ottawa Ontario Canada"],"raw_orcid":"https://orcid.org/0000-0002-9253-248X","affiliations":[{"raw_affiliation_string":"Department of Medicine University of Ottawa at the Ottawa Hospital  Ottawa Ontario Canada","institution_ids":["https://openalex.org/I153718931","https://openalex.org/I2800722420"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103069650","display_name":"Joseph R. Shaw","orcid":"https://orcid.org/0000-0002-2217-9211","observed_orcids":["https://orcid.org/0000-0002-2217-9211","https://orcid.org/0000-0002-2405-7912"]},"institutions":[{"id":"https://openalex.org/I153718931","display_name":"University of Ottawa","ror":"https://ror.org/03c4mmv16","country_code":"CA","type":"education","lineage":["https://openalex.org/I153718931"]},{"id":"https://openalex.org/I2800722420","display_name":"Ottawa Hospital","ror":"https://ror.org/03c62dg59","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2800722420"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Joseph Shaw","raw_affiliation_strings":["Department of Medicine University of Ottawa at the Ottawa Hospital  Ottawa Ontario Canada"],"raw_orcid":"https://orcid.org/0000-0002-2405-7912","affiliations":[{"raw_affiliation_string":"Department of Medicine University of Ottawa at the Ottawa Hospital  Ottawa Ontario Canada","institution_ids":["https://openalex.org/I153718931","https://openalex.org/I2800722420"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014879812","display_name":"Danny Hill","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210109472","display_name":"Sault Area Hospital","ror":"https://ror.org/01sqn6v38","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I4210109472"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Danny Hill","raw_affiliation_strings":["Department of Medicine Sault Area Hospital  Sault Ste. Marie Ontario Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine Sault Area Hospital  Sault Ste. Marie Ontario Canada","institution_ids":["https://openalex.org/I4210109472"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018625771","display_name":"Sudeep Shivakumar","orcid":"https://orcid.org/0000-0003-0239-1802","observed_orcids":["https://orcid.org/0000-0003-0239-1802"]},"institutions":[{"id":"https://openalex.org/I129902397","display_name":"Dalhousie University","ror":"https://ror.org/01e6qks80","country_code":"CA","type":"education","lineage":["https://openalex.org/I129902397"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Sudeep Shivakumar","raw_affiliation_strings":["Department of Medicine Nova Scotia Health, Dalhousie University  Halifax Nova Scotia Canada"],"raw_orcid":"https://orcid.org/0000-0003-0239-1802","affiliations":[{"raw_affiliation_string":"Department of Medicine Nova Scotia Health, Dalhousie University  Halifax Nova Scotia Canada","institution_ids":["https://openalex.org/I129902397"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081425242","display_name":"Vicky Tagalakis","orcid":"https://orcid.org/0000-0003-2909-3143","observed_orcids":["https://orcid.org/0000-0003-2909-3143"]},"institutions":[{"id":"https://openalex.org/I4405267356","display_name":"Lady Davis Institute for Medical Research","ror":"https://ror.org/02c1np254","country_code":"CA","type":"education","lineage":["https://openalex.org/I2801824472","https://openalex.org/I2801902503","https://openalex.org/I4210139015","https://openalex.org/I4405256057","https://openalex.org/I4405267356","https://openalex.org/I4405279980"]},{"id":"https://openalex.org/I5023651","display_name":"McGill University","ror":"https://ror.org/01pxwe438","country_code":"CA","type":"education","lineage":["https://openalex.org/I5023651"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Vicky Tagalakis","raw_affiliation_strings":["Jewish General Hospital, Lady Davis Institute for Medical Research McGill University  Montreal Quebec Canada"],"raw_orcid":"https://orcid.org/0000-0003-2909-3143","affiliations":[{"raw_affiliation_string":"Jewish General Hospital, Lady Davis Institute for Medical Research McGill University  Montreal Quebec Canada","institution_ids":["https://openalex.org/I4405267356","https://openalex.org/I5023651"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5105782058","display_name":"Philip Stephen Wells","orcid":"https://orcid.org/0000-0002-8657-8326","observed_orcids":["https://orcid.org/0000-0002-8657-8326"]},"institutions":[{"id":"https://openalex.org/I153718931","display_name":"University of Ottawa","ror":"https://ror.org/03c4mmv16","country_code":"CA","type":"education","lineage":["https://openalex.org/I153718931"]},{"id":"https://openalex.org/I2800722420","display_name":"Ottawa Hospital","ror":"https://ror.org/03c62dg59","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2800722420"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Phil Wells","raw_affiliation_strings":["Department of Medicine University of Ottawa at the Ottawa Hospital  Ottawa Ontario Canada"],"raw_orcid":"https://orcid.org/0000-0002-8657-8326","affiliations":[{"raw_affiliation_string":"Department of Medicine University of Ottawa at the Ottawa Hospital  Ottawa Ontario Canada","institution_ids":["https://openalex.org/I153718931","https://openalex.org/I2800722420"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5054511215","display_name":"Marc Carrier","orcid":"https://orcid.org/0000-0001-8296-2972","observed_orcids":["https://orcid.org/0000-0001-8296-2972"]},"institutions":[{"id":"https://openalex.org/I153718931","display_name":"University of Ottawa","ror":"https://ror.org/03c4mmv16","country_code":"CA","type":"education","lineage":["https://openalex.org/I153718931"]},{"id":"https://openalex.org/I2800722420","display_name":"Ottawa Hospital","ror":"https://ror.org/03c62dg59","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2800722420"]}],"countries":["CA"],"is_corresponding":true,"raw_author_name":"Marc Carrier","raw_affiliation_strings":["Department of Medicine University of Ottawa at the Ottawa Hospital  Ottawa Ontario Canada"],"raw_orcid":"https://orcid.org/0000-0001-8296-2972","affiliations":[{"raw_affiliation_string":"Department of Medicine University of Ottawa at the Ottawa Hospital  Ottawa Ontario Canada","institution_ids":["https://openalex.org/I153718931","https://openalex.org/I2800722420"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":8,"corresponding_author_ids":["https://openalex.org/A5054511215"],"corresponding_institution_ids":["https://openalex.org/I153718931","https://openalex.org/I2800722420"],"apc_list":{"value":4700,"currency":"USD","value_usd":4700},"apc_paid":{"value":4700,"currency":"USD","value_usd":4700},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.84796196,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"15","issue":"11","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10285","display_name":"Venous Thromboembolism Diagnosis and Management","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2724","display_name":"Internal Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10285","display_name":"Venous Thromboembolism Diagnosis and Management","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2724","display_name":"Internal Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10881","display_name":"Blood Coagulation and Thrombosis Mechanisms","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11355","display_name":"Inflammatory Biomarkers in Disease Prognosis","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/apixaban","display_name":"apixaban","score":1.0},{"id":"https://openalex.org/keywords/venous-thromboembolism","display_name":"venous thromboembolism","score":0.8840000033378601},{"id":"https://openalex.org/keywords/cancer-associated-thrombosis","display_name":"cancer-associated thrombosis","score":0.7689999938011169},{"id":"https://openalex.org/keywords/thromboprophylaxis","display_name":"thromboprophylaxis","score":0.9399999976158142},{"id":"https://openalex.org/keywords/chemotherapy","display_name":"chemotherapy","score":0.47600001096725464},{"id":"https://openalex.org/keywords/platinum-based-chemotherapy","display_name":"platinum-based chemotherapy","score":0.9850000143051147},{"id":"https://openalex.org/keywords/taxanes","display_name":"taxanes","score":0.8579999804496765},{"id":"https://openalex.org/keywords/topoisomerase-inhibitors","display_name":"topoisomerase inhibitors","score":0.9890000224113464},{"id":"https://openalex.org/keywords/antimetabolites","display_name":"antimetabolites","score":0.9700000286102295},{"id":"https://openalex.org/keywords/bleeding-risk","display_name":"bleeding risk","score":0.7419999837875366},{"id":"https://openalex.org/keywords/avert-trial","display_name":"AVERT trial","score":0.8730000257492065},{"id":"https://openalex.org/keywords/ambulatory-cancer-patients","display_name":"ambulatory cancer patients","score":0.8880000114440918},{"id":"https://openalex.org/keywords/subgroup-analysis","display_name":"subgroup analysis","score":0.49900001287460327},{"id":"https://openalex.org/keywords/anticoagulant-efficacy-and-safety","display_name":"anticoagulant efficacy and safety","score":0.6420000195503235}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9172999858856201},{"id":"https://openalex.org/C2780638905","wikidata":"https://www.wikidata.org/wiki/Q414462","display_name":"Apixaban","level":5,"score":0.8030999898910522},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6432999968528748},{"id":"https://openalex.org/C67761136","wikidata":"https://www.wikidata.org/wiki/Q2105849","display_name":"Post-hoc analysis","level":2,"score":0.6399999856948853},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.5710999965667725},{"id":"https://openalex.org/C35785553","wikidata":"https://www.wikidata.org/wiki/Q756720","display_name":"Ambulatory","level":2,"score":0.5634999871253967},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.5216000080108643},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.48069998621940613},{"id":"https://openalex.org/C50382708","wikidata":"https://www.wikidata.org/wiki/Q223218","display_name":"Proportional hazards model","level":2,"score":0.44369998574256897},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.3693999946117401},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3621000051498413},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.36059999465942383},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.35899999737739563},{"id":"https://openalex.org/C2777511904","wikidata":"https://www.wikidata.org/wiki/Q425227","display_name":"Taxane","level":4,"score":0.3424000144004822},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3330000042915344},{"id":"https://openalex.org/C2780835546","wikidata":"https://www.wikidata.org/wiki/Q425122","display_name":"Epirubicin","level":4,"score":0.3212999999523163},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.31220000982284546},{"id":"https://openalex.org/C2780645631","wikidata":"https://www.wikidata.org/wiki/Q671554","display_name":"Stroke (engine)","level":2,"score":0.2944999933242798},{"id":"https://openalex.org/C187960798","wikidata":"https://www.wikidata.org/wiki/Q7631152","display_name":"Subgroup analysis","level":3,"score":0.2791999876499176},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.2705000042915344},{"id":"https://openalex.org/C17923572","wikidata":"https://www.wikidata.org/wiki/Q7250160","display_name":"Propensity score matching","level":2,"score":0.2581999897956848},{"id":"https://openalex.org/C77350462","wikidata":"https://www.wikidata.org/wiki/Q1125472","display_name":"Confounding","level":2,"score":0.2572000026702881}],"mesh":[{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006470","descriptor_name":"Hemorrhage","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D006470","descriptor_name":"Hemorrhage","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D011720","descriptor_name":"Pyrazoles","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D011720","descriptor_name":"Pyrazoles","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D011720","descriptor_name":"Pyrazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011728","descriptor_name":"Pyridones","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D011728","descriptor_name":"Pyridones","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D011728","descriptor_name":"Pyridones","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D054556","descriptor_name":"Venous Thromboembolism","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":true},{"descriptor_ui":"D054556","descriptor_name":"Venous Thromboembolism","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D065427","descriptor_name":"Factor Xa Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D065427","descriptor_name":"Factor Xa Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D065427","descriptor_name":"Factor Xa Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1002/cam4.72423","doi":"https://doi.org/10.1002/cam4.72423","is_oa":true,"landing_page_url":"https://doi.org/10.1002/cam4.72423","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cam4.72423","source":{"id":"https://openalex.org/S2754843627","display_name":"Cancer Medicine","issn_l":"2045-7634","issn":["2045-7634"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Medicine","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13696908","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13696908/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13696908/pdf/CAM4-15-e72423.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Med","raw_type":"Text"},{"id":"pmid:42928572","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42928572","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer medicine","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1002/cam4.72423","doi":"https://doi.org/10.1002/cam4.72423","is_oa":true,"landing_page_url":"https://doi.org/10.1002/cam4.72423","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cam4.72423","source":{"id":"https://openalex.org/S2754843627","display_name":"Cancer Medicine","issn_l":"2045-7634","issn":["2045-7634"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Medicine","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307115","display_name":"Bristol-Myers Squibb","ror":"https://ror.org/00gtmwv55"},{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"},{"id":"https://openalex.org/F4320307781","display_name":"Sanofi","ror":"https://ror.org/027vj4x92"},{"id":"https://openalex.org/F4320310630","display_name":"University of Ottawa","ror":"https://ror.org/03c4mmv16"},{"id":"https://openalex.org/F4320321625","display_name":"Daiichi-Sankyo","ror":"https://ror.org/027y26122"},{"id":"https://openalex.org/F4320327235","display_name":"Servier","ror":"https://ror.org/034e7c066"},{"id":"https://openalex.org/F4320332071","display_name":"LEO Pharma","ror":"https://ror.org/05tzrdd39"},{"id":"https://openalex.org/F4320338262","display_name":"Daiichi Sankyo Europe","ror":"https://ror.org/01qhj1g70"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7223648928.pdf","grobid_xml":"https://content.openalex.org/works/W7223648928.grobid-xml"},"referenced_works_count":20,"referenced_works":["https://openalex.org/W1995828607","https://openalex.org/W2062257866","https://openalex.org/W2093389482","https://openalex.org/W2151349963","https://openalex.org/W2162499932","https://openalex.org/W2199506938","https://openalex.org/W2783503000","https://openalex.org/W2884379119","https://openalex.org/W2897723485","https://openalex.org/W2902078827","https://openalex.org/W2917037555","https://openalex.org/W2917722773","https://openalex.org/W2989714602","https://openalex.org/W3127460195","https://openalex.org/W3141105901","https://openalex.org/W4220748501","https://openalex.org/W4283694425","https://openalex.org/W4318946166","https://openalex.org/W4401344760","https://openalex.org/W4415803870"],"related_works":["https://openalex.org/W2988863151","https://openalex.org/W3095655536","https://openalex.org/W3209289204","https://openalex.org/W3213207497","https://openalex.org/W2800689473","https://openalex.org/W3030822267","https://openalex.org/W2134683286","https://openalex.org/W2921034611","https://openalex.org/W4282025629","https://openalex.org/W2154738014"],"abstract_inverted_index":{"BACKGROUND:":[0],"Venous":[1],"thromboembolism":[2],"(VTE)":[3],"is":[4],"a":[5,46,214],"leading":[6],"cause":[7],"of":[8,33,54,144,217,286],"morbidity":[9],"and":[10,31,81,117,126,149,195],"mortality":[11],"in":[12,23,69,167,283],"cancer":[13,71],"patients.":[14,237],"The":[15,75],"AVERT":[16,59],"trial":[17,60],"showed":[18],"apixaban":[19,34,62,162,256],"thromboprophylaxis":[20,257,282],"reduced":[21,261],"VTE":[22,166,218,262],"intermediate-to-high-risk":[24],"patients":[25,72,146,168],"initiating":[26,73],"chemotherapy.":[27,74,108],"However,":[28],"the":[29,55,82,284],"efficacy":[30,77],"safety":[32,84,270],"according":[35],"to":[36,134,164],"baseline":[37],"chemotherapy":[38,52,155,210,265,275],"class":[39,53],"remain":[40],"incompletely":[41],"characterized.":[42],"METHODS:":[43],"We":[44],"conducted":[45],"post":[47],"hoc":[48],"analysis":[49,103],"stratified":[50],"by":[51,138,151,247],"randomized,":[56],"double-blind,":[57],"placebo-controlled":[58],"comparing":[61],"(2.5":[63],"mg":[64],"twice":[65],"daily)":[66],"with":[67,106,160,213,220,260,267],"placebo":[68],"ambulatory":[70],"primary":[76,83],"outcome":[78,85],"was":[79,86,211,233,258],"VTE,":[80],"clinically":[87,92],"relevant":[88,93],"bleeding":[89,96],"(major":[90],"or":[91,153],"non":[94],"major":[95],"(CRNMB))":[97],"per":[98],"ISTH":[99],"criteria.":[100],"A":[101,142],"subgroup":[102],"compared":[104,219],"platinum-based":[105,209,274],"non-platinum":[107,221],"Cox":[109],"proportional":[110],"hazards":[111],"models":[112],"estimated":[113],"hazard":[114],"ratios":[115],"(HRs)":[116],"95%":[118,173,179,185,192,200,225],"confidence":[119],"intervals":[120],"(CI),":[121],"adjusted":[122],"for":[123],"age,":[124],"sex,":[125],"study":[127],"site.":[128],"Treatment-by-platinum":[129,238],"interaction":[130,239],"terms":[131],"were":[132,147],"used":[133],"assess":[135],"effect":[136,245],"modification":[137,246],"platinum":[139,170,248],"exposure.":[140,249],"RESULTS:":[141],"total":[143],"563":[145],"included":[148],"categorized":[150],"one":[152],"more":[154],"classes":[156],"at":[157],"randomization.":[158],"Compared":[159],"placebo,":[161],"appeared":[163],"reduce":[165],"on":[169],"(HR":[171,177,183,190,198,223],"0.30,":[172],"CI":[174,180,186,193,201,226],"0.16-0.57),":[175],"taxane":[176],"0.42,":[178],"0.23-0.75),":[181],"taxane-platinum":[182],"0.28,":[184],"0.12-0.68),":[187],"topoisomerase":[188],"inhibitor":[189],"0.32,":[191],"0.19-0.53),":[194],"antimetabolite":[196],"regimens":[197,222,266],"0.25,":[199],"0.12-0.54),":[202],"without":[203],"increased":[204],"bleeding.":[205],"Among":[206],"placebo-treated":[207],"patients,":[208],"associated":[212,259],"higher":[215,287],"risk":[216],"2.25,":[224],"1.48-3.42),":[227],"whereas":[228],"no":[229],"statistically":[230],"significant":[231,244],"difference":[232],"observed":[234],"among":[235],"apixaban-treated":[236],"testing":[240],"did":[241],"not":[242],"demonstrate":[243],"CONCLUSION:":[250],"In":[251],"this":[252],"exploratory,":[253],"hypothesis-generating":[254],"analysis,":[255],"across":[263],"several":[264],"generally":[268],"acceptable":[269],"outcomes.":[271],"Patients":[272],"receiving":[273],"may":[276],"derive":[277],"greater":[278],"absolute":[279],"benefit":[280],"from":[281],"setting":[285],"underlying":[288],"thrombotic":[289],"risk.":[290]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2026-10-27T00:00:00"}